核医学同位体の世界市場 2020年

• 英文タイトル：Global Nuclear Medicine Isotopes Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：GIR201114671 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、122ページ • 納品方法：Eメール • 産業分類：医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本書では、核医学同位体の世界市場を調査対象にし、核医学同位体の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（安定同位体、放射性同位元素）、用途別分析（核治療、機器、放射線源、診断）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：NRG、Cambridge Isotope Laboratories、ANSTO、NTP Radioisotopes、Curium Pharma、JSC Isotope、Polatom、Nordion、IRE、Eckert & Ziegler Strahlen、Shanghai Engineering Research Center、Linde、Center of Molecular Research、SI Science、IDB Holland、LANL、China National Nuclear Corporation、ORNL、NHTC、Urenco ・企業別売上、市場シェア ・核医学同位体の地域別市場分析 ・核医学同位体の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・核医学同位体のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・核医学同位体のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・核医学同位体の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・核医学同位体の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・核医学同位体の種類別市場規模2015-2020：安定同位体、放射性同位元素 ・核医学同位体の用途別市場規模2015-2020：核治療、機器、放射線源、診断 ・核医学同位体の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論

Market Overview
The Nuclear Medicine Isotopes market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global Nuclear Medicine Isotopes market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

Market segmentation
Nuclear Medicine Isotopes market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Nuclear Medicine Isotopes market has been segmented into:
Stable Isotopes
Radioisotopes

By Application, Nuclear Medicine Isotopes has been segmented into:
Nuclear Therapy
Equipment Radioactive Source
Diagnosis

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Nuclear Medicine Isotopes market presented in the report. This section sheds light on the sales growth of different regional and country-level Nuclear Medicine Isotopes markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Nuclear Medicine Isotopes market.

The report offers in-depth assessment of the growth and other aspects of the Nuclear Medicine Isotopes market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Nuclear Medicine Isotopes Market Share Analysis
Nuclear Medicine Isotopes competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Nuclear Medicine Isotopes sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Nuclear Medicine Isotopes sales, revenue and market share for each player covered in this report.

The major players covered in Nuclear Medicine Isotopes are:
NRG
Cambridge Isotope Laboratories
ANSTO
NTP Radioisotopes
Curium Pharma
JSC Isotope
Polatom
Nordion
IRE
Eckert & Ziegler Strahlen
Shanghai Engineering Research Center
Linde
Center of Molecular Research
SI Science
IDB Holland
LANL
China National Nuclear Corporation
ORNL
NHTC
Urenco
Among other players domestic and global, Nuclear Medicine Isotopes market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

レポート目次

---

1 Nuclear Medicine Isotopes Market Overview
1.1 Product Overview and Scope of Nuclear Medicine Isotopes
1.2 Classification of Nuclear Medicine Isotopes by Type
1.2.1 Global Nuclear Medicine Isotopes Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Nuclear Medicine Isotopes Revenue Market Share by Type in 2019
1.2.3 Stable Isotopes
1.2.4 Radioisotopes
1.3 Global Nuclear Medicine Isotopes Market by Application
1.3.1 Overview: Global Nuclear Medicine Isotopes Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Nuclear Therapy
1.3.3 Equipment Radioactive Source
1.3.4 Diagnosis
1.4 Global Nuclear Medicine Isotopes Market by Regions
1.4.1 Global Nuclear Medicine Isotopes Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Nuclear Medicine Isotopes (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Nuclear Medicine Isotopes Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Nuclear Medicine Isotopes Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Nuclear Medicine Isotopes Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Nuclear Medicine Isotopes Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Nuclear Medicine Isotopes Status and Prospect (2015-2025)
2 Company Profiles
2.1 NRG
2.1.1 NRG Details
2.1.2 NRG Major Business
2.1.3 NRG SWOT Analysis
2.1.4 NRG Product and Services
2.1.5 NRG Nuclear Medicine Isotopes Revenue, Gross Margin and Market Share (2018-2019)
2.2 Cambridge Isotope Laboratories
2.2.1 Cambridge Isotope Laboratories Details
2.2.2 Cambridge Isotope Laboratories Major Business
2.2.3 Cambridge Isotope Laboratories SWOT Analysis
2.2.4 Cambridge Isotope Laboratories Product and Services
2.2.5 Cambridge Isotope Laboratories Nuclear Medicine Isotopes Revenue, Gross Margin and Market Share (2018-2019)
2.3 ANSTO
2.3.1 ANSTO Details
2.3.2 ANSTO Major Business
2.3.3 ANSTO SWOT Analysis
2.3.4 ANSTO Product and Services
2.3.5 ANSTO Nuclear Medicine Isotopes Revenue, Gross Margin and Market Share (2018-2019)
2.4 NTP Radioisotopes
2.4.1 NTP Radioisotopes Details
2.4.2 NTP Radioisotopes Major Business
2.4.3 NTP Radioisotopes SWOT Analysis
2.4.4 NTP Radioisotopes Product and Services
2.4.5 NTP Radioisotopes Nuclear Medicine Isotopes Revenue, Gross Margin and Market Share (2018-2019)
2.5 Curium Pharma
2.5.1 Curium Pharma Details
2.5.2 Curium Pharma Major Business
2.5.3 Curium Pharma SWOT Analysis
2.5.4 Curium Pharma Product and Services
2.5.5 Curium Pharma Nuclear Medicine Isotopes Revenue, Gross Margin and Market Share (2018-2019)
2.6 JSC Isotope
2.6.1 JSC Isotope Details
2.6.2 JSC Isotope Major Business
2.6.3 JSC Isotope Product and Services
2.6.4 JSC Isotope Nuclear Medicine Isotopes Revenue, Gross Margin and Market Share (2018-2019)
2.7 Polatom
2.7.1 Polatom Details
2.7.2 Polatom Major Business
2.7.3 Polatom Product and Services
2.7.4 Polatom Nuclear Medicine Isotopes Revenue, Gross Margin and Market Share (2018-2019)
2.8 Nordion
2.8.1 Nordion Details
2.8.2 Nordion Major Business
2.8.3 Nordion Product and Services
2.8.4 Nordion Nuclear Medicine Isotopes Revenue, Gross Margin and Market Share (2018-2019)
2.9 IRE
2.9.1 IRE Details
2.9.2 IRE Major Business
2.9.3 IRE Product and Services
2.9.4 IRE Nuclear Medicine Isotopes Revenue, Gross Margin and Market Share (2018-2019)
2.10 Eckert & Ziegler Strahlen
2.10.1 Eckert & Ziegler Strahlen Details
2.10.2 Eckert & Ziegler Strahlen Major Business
2.10.3 Eckert & Ziegler Strahlen Product and Services
2.10.4 Eckert & Ziegler Strahlen Nuclear Medicine Isotopes Revenue, Gross Margin and Market Share (2018-2019)
2.11 Shanghai Engineering Research Center
2.11.1 Shanghai Engineering Research Center Details
2.11.2 Shanghai Engineering Research Center Major Business
2.11.3 Shanghai Engineering Research Center Product and Services
2.11.4 Shanghai Engineering Research Center Nuclear Medicine Isotopes Revenue, Gross Margin and Market Share (2018-2019)
2.12 Linde
2.12.1 Linde Details
2.12.2 Linde Major Business
2.12.3 Linde Product and Services
2.12.4 Linde Nuclear Medicine Isotopes Revenue, Gross Margin and Market Share (2018-2019)
2.13 Center of Molecular Research
2.13.1 Center of Molecular Research Details
2.13.2 Center of Molecular Research Major Business
2.13.3 Center of Molecular Research Product and Services
2.13.4 Center of Molecular Research Nuclear Medicine Isotopes Revenue, Gross Margin and Market Share (2018-2019)
2.14 SI Science
2.14.1 SI Science Details
2.14.2 SI Science Major Business
2.14.3 SI Science Product and Services
2.14.4 SI Science Nuclear Medicine Isotopes Revenue, Gross Margin and Market Share (2018-2019)
2.15 IDB Holland
2.15.1 IDB Holland Details
2.15.2 IDB Holland Major Business
2.15.3 IDB Holland Product and Services
2.15.4 IDB Holland Nuclear Medicine Isotopes Revenue, Gross Margin and Market Share (2018-2019)
2.16 LANL
2.16.1 LANL Details
2.16.2 LANL Major Business
2.16.3 LANL Product and Services
2.16.4 LANL Nuclear Medicine Isotopes Revenue, Gross Margin and Market Share (2018-2019)
2.17 China National Nuclear Corporation
2.17.1 China National Nuclear Corporation Details
2.17.2 China National Nuclear Corporation Major Business
2.17.3 China National Nuclear Corporation Product and Services
2.17.4 China National Nuclear Corporation Nuclear Medicine Isotopes Revenue, Gross Margin and Market Share (2018-2019)
2.18 ORNL
2.18.1 ORNL Details
2.18.2 ORNL Major Business
2.18.3 ORNL Product and Services
2.18.3 ORNL Nuclear Medicine Isotopes Revenue, Gross Margin and Market Share (2018-2019)
2.19 NHTC
2.19.1 NHTC Details
2.19.2 NHTC Major Business
2.19.3 NHTC Product and Services
2.19.4 NHTC Nuclear Medicine Isotopes Revenue, Gross Margin and Market Share (2018-2019)
2.20 Urenco
2.20.1 Urenco Details
2.20.2 Urenco Major Business
2.20.3 Urenco Product and Services
2.20.4 Urenco Nuclear Medicine Isotopes Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Nuclear Medicine Isotopes Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Nuclear Medicine Isotopes Players Market Share
3.2.2 Top 10 Nuclear Medicine Isotopes Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Nuclear Medicine Isotopes Revenue and Market Share by Regions
4.2 North America Nuclear Medicine Isotopes Revenue and Growth Rate (2015-2020)
4.3 Europe Nuclear Medicine Isotopes Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Nuclear Medicine Isotopes Revenue and Growth Rate (2015-2020)
4.5 South America Nuclear Medicine Isotopes Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Nuclear Medicine Isotopes Revenue and Growth Rate (2015-2020)
5 North America Nuclear Medicine Isotopes Revenue by Countries
5.1 North America Nuclear Medicine Isotopes Revenue by Countries (2015-2020)
5.2 USA Nuclear Medicine Isotopes Revenue and Growth Rate (2015-2020)
5.3 Canada Nuclear Medicine Isotopes Revenue and Growth Rate (2015-2020)
5.4 Mexico Nuclear Medicine Isotopes Revenue and Growth Rate (2015-2020)
6 Europe Nuclear Medicine Isotopes Revenue by Countries
6.1 Europe Nuclear Medicine Isotopes Revenue by Countries (2015-2020)
6.2 Germany Nuclear Medicine Isotopes Revenue and Growth Rate (2015-2020)
6.3 UK Nuclear Medicine Isotopes Revenue and Growth Rate (2015-2020)
6.4 France Nuclear Medicine Isotopes Revenue and Growth Rate (2015-2020)
6.5 Russia Nuclear Medicine Isotopes Revenue and Growth Rate (2015-2020)
6.6 Italy Nuclear Medicine Isotopes Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Nuclear Medicine Isotopes Revenue by Countries
7.1 Asia-Pacific Nuclear Medicine Isotopes Revenue by Countries (2015-2020)
7.2 China Nuclear Medicine Isotopes Revenue and Growth Rate (2015-2020)
7.3 Japan Nuclear Medicine Isotopes Revenue and Growth Rate (2015-2020)
7.4 Korea Nuclear Medicine Isotopes Revenue and Growth Rate (2015-2020)
7.5 India Nuclear Medicine Isotopes Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Nuclear Medicine Isotopes Revenue and Growth Rate (2015-2020)
8 South America Nuclear Medicine Isotopes Revenue by Countries
8.1 South America Nuclear Medicine Isotopes Revenue by Countries (2015-2020)
8.2 Brazil Nuclear Medicine Isotopes Revenue and Growth Rate (2015-2020)
8.3 Argentina Nuclear Medicine Isotopes Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Nuclear Medicine Isotopes by Countries
9.1 Middle East & Africa Nuclear Medicine Isotopes Revenue by Countries (2015-2020)
9.2 Saudi Arabia Nuclear Medicine Isotopes Revenue and Growth Rate (2015-2020)
9.3 UAE Nuclear Medicine Isotopes Revenue and Growth Rate (2015-2020)
9.4 Egypt Nuclear Medicine Isotopes Revenue and Growth Rate (2015-2020)
9.5 South Africa Nuclear Medicine Isotopes Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Nuclear Medicine Isotopes Revenue and Market Share by Type (2015-2020)
10.2 Global Nuclear Medicine Isotopes Market Forecast by Type (2019-2024)
10.3 Stable Isotopes Revenue Growth Rate (2015-2025)
10.4 Radioisotopes Revenue Growth Rate (2015-2025)
11 Global Nuclear Medicine Isotopes Market Segment by Application
11.1 Global Nuclear Medicine Isotopes Revenue Market Share by Application (2015-2020)
11.2 Nuclear Medicine Isotopes Market Forecast by Application (2019-2024)
11.3 Nuclear Therapy Revenue Growth (2015-2020)
11.4 Equipment Radioactive Source Revenue Growth (2015-2020)
11.5 Diagnosis Revenue Growth (2015-2020)
12 Global Nuclear Medicine Isotopes Market Size Forecast (2021-2025)
12.1 Global Nuclear Medicine Isotopes Market Size Forecast (2021-2025)
12.2 Global Nuclear Medicine Isotopes Market Forecast by Regions (2021-2025)
12.3 North America Nuclear Medicine Isotopes Revenue Market Forecast (2021-2025)
12.4 Europe Nuclear Medicine Isotopes Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Nuclear Medicine Isotopes Revenue Market Forecast (2021-2025)
12.6 South America Nuclear Medicine Isotopes Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Nuclear Medicine Isotopes Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables
Table 1. Global Nuclear Medicine Isotopes Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Nuclear Medicine Isotopes by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Nuclear Medicine Isotopes Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Nuclear Medicine Isotopes Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Nuclear Medicine Isotopes Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. NRG Corporate Information, Location and Competitors
Table 7. NRG Nuclear Medicine Isotopes Major Business
Table 8. NRG Nuclear Medicine Isotopes Total Revenue (USD Million) (2017-2018)
Table 9. NRG SWOT Analysis
Table 10. NRG Nuclear Medicine Isotopes Product and Solutions
Table 11. NRG Nuclear Medicine Isotopes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Cambridge Isotope Laboratories Corporate Information, Location and Competitors
Table 13. Cambridge Isotope Laboratories Nuclear Medicine Isotopes Major Business
Table 14. Cambridge Isotope Laboratories Nuclear Medicine Isotopes Total Revenue (USD Million) (2018-2019)
Table 15. Cambridge Isotope Laboratories SWOT Analysis
Table 16. Cambridge Isotope Laboratories Nuclear Medicine Isotopes Product and Solutions
Table 17. Cambridge Isotope Laboratories Nuclear Medicine Isotopes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. ANSTO Corporate Information, Location and Competitors
Table 19. ANSTO Nuclear Medicine Isotopes Major Business
Table 20. ANSTO Nuclear Medicine Isotopes Total Revenue (USD Million) (2017-2018)
Table 21. ANSTO SWOT Analysis
Table 22. ANSTO Nuclear Medicine Isotopes Product and Solutions
Table 23. ANSTO Nuclear Medicine Isotopes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. NTP Radioisotopes Corporate Information, Location and Competitors
Table 25. NTP Radioisotopes Nuclear Medicine Isotopes Major Business
Table 26. NTP Radioisotopes Nuclear Medicine Isotopes Total Revenue (USD Million) (2017-2018)
Table 27. NTP Radioisotopes SWOT Analysis
Table 28. NTP Radioisotopes Nuclear Medicine Isotopes Product and Solutions
Table 29. NTP Radioisotopes Nuclear Medicine Isotopes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Curium Pharma Corporate Information, Location and Competitors
Table 31. Curium Pharma Nuclear Medicine Isotopes Major Business
Table 32. Curium Pharma Nuclear Medicine Isotopes Total Revenue (USD Million) (2017-2018)
Table 33. Curium Pharma SWOT Analysis
Table 34. Curium Pharma Nuclear Medicine Isotopes Product and Solutions
Table 35. Curium Pharma Nuclear Medicine Isotopes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. JSC Isotope Corporate Information, Location and Competitors
Table 37. JSC Isotope Nuclear Medicine Isotopes Major Business
Table 38. JSC Isotope Nuclear Medicine Isotopes Total Revenue (USD Million) (2017-2018)
Table 39. JSC Isotope SWOT Analysis
Table 40. JSC Isotope Nuclear Medicine Isotopes Product and Solutions
Table 41. JSC Isotope Nuclear Medicine Isotopes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Polatom Corporate Information, Location and Competitors
Table 43. Polatom Nuclear Medicine Isotopes Major Business
Table 44. Polatom Nuclear Medicine Isotopes Total Revenue (USD Million) (2017-2018)
Table 45. Polatom SWOT Analysis
Table 46. Polatom Nuclear Medicine Isotopes Product and Solutions
Table 47. Polatom Nuclear Medicine Isotopes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Nordion Corporate Information, Location and Competitors
Table 49. Nordion Nuclear Medicine Isotopes Major Business
Table 50. Nordion Nuclear Medicine Isotopes Total Revenue (USD Million) (2017-2018)
Table 51. Nordion SWOT Analysis
Table 52. Nordion Nuclear Medicine Isotopes Product and Solutions
Table 53. Nordion Nuclear Medicine Isotopes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. IRE Corporate Information, Location and Competitors
Table 55. IRE Nuclear Medicine Isotopes Major Business
Table 56. IRE Nuclear Medicine Isotopes Total Revenue (USD Million) (2017-2018)
Table 57. IRE SWOT Analysis
Table 58. IRE Nuclear Medicine Isotopes Product and Solutions
Table 59. IRE Nuclear Medicine Isotopes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Eckert & Ziegler Strahlen Corporate Information, Location and Competitors
Table 61. Eckert & Ziegler Strahlen Nuclear Medicine Isotopes Major Business
Table 62. Eckert & Ziegler Strahlen Nuclear Medicine Isotopes Total Revenue (USD Million) (2017-2018)
Table 63. Eckert & Ziegler Strahlen SWOT Analysis
Table 64. Eckert & Ziegler Strahlen Nuclear Medicine Isotopes Product and Solutions
Table 65. Eckert & Ziegler Strahlen Nuclear Medicine Isotopes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Shanghai Engineering Research Center Corporate Information, Location and Competitors
Table 67. Shanghai Engineering Research Center Nuclear Medicine Isotopes Major Business
Table 68. Shanghai Engineering Research Center Nuclear Medicine Isotopes Total Revenue (USD Million) (2017-2018)
Table 69. Shanghai Engineering Research Center SWOT Analysis
Table 70. Shanghai Engineering Research Center Nuclear Medicine Isotopes Product and Solutions
Table 71. Shanghai Engineering Research Center Nuclear Medicine Isotopes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Linde Corporate Information, Location and Competitors
Table 73. Linde Nuclear Medicine Isotopes Major Business
Table 74. Linde Nuclear Medicine Isotopes Total Revenue (USD Million) (2017-2018)
Table 75. Linde SWOT Analysis
Table 76. Linde Nuclear Medicine Isotopes Product and Solutions
Table 77. Linde Nuclear Medicine Isotopes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. Center of Molecular Research Corporate Information, Location and Competitors
Table 79. Center of Molecular Research Nuclear Medicine Isotopes Major Business
Table 80. Center of Molecular Research Nuclear Medicine Isotopes Total Revenue (USD Million) (2017-2018)
Table 81. Center of Molecular Research SWOT Analysis
Table 82. Center of Molecular Research Nuclear Medicine Isotopes Product and Solutions
Table 83. Center of Molecular Research Nuclear Medicine Isotopes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 84. SI Science Corporate Information, Location and Competitors
Table 85. SI Science Nuclear Medicine Isotopes Major Business
Table 86. SI Science Nuclear Medicine Isotopes Total Revenue (USD Million) (2017-2018)
Table 87. SI Science SWOT Analysis
Table 88. SI Science Nuclear Medicine Isotopes Product and Solutions
Table 89. SI Science Nuclear Medicine Isotopes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 90. IDB Holland Corporate Information, Location and Competitors
Table 91. IDB Holland Nuclear Medicine Isotopes Major Business
Table 92. IDB Holland Nuclear Medicine Isotopes Total Revenue (USD Million) (2017-2018)
Table 93. IDB Holland SWOT Analysis
Table 94. IDB Holland Nuclear Medicine Isotopes Product and Solutions
Table 95. IDB Holland Nuclear Medicine Isotopes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 96. LANL Corporate Information, Location and Competitors
Table 97. LANL Nuclear Medicine Isotopes Major Business
Table 98. LANL Nuclear Medicine Isotopes Total Revenue (USD Million) (2017-2018)
Table 99. LANL SWOT Analysis
Table 100. LANL Nuclear Medicine Isotopes Product and Solutions
Table 101. LANL Nuclear Medicine Isotopes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 102. China National Nuclear Corporation Corporate Information, Location and Competitors
Table 103. China National Nuclear Corporation Nuclear Medicine Isotopes Major Business
Table 104. China National Nuclear Corporation Nuclear Medicine Isotopes Total Revenue (USD Million) (2017-2018)
Table 105. China National Nuclear Corporation SWOT Analysis
Table 106. China National Nuclear Corporation Nuclear Medicine Isotopes Product and Solutions
Table 107. China National Nuclear Corporation Nuclear Medicine Isotopes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 108. ORNL Nuclear Medicine Isotopes Type and Application
Table 109. ORNL Nuclear Medicine Isotopes Major Business
Table 110. ORNL Nuclear Medicine Isotopes Total Revenue (USD Million) (2017-2018)
Table 111. ORNL SWOT Analysis
Table 112. ORNL Nuclear Medicine Isotopes Product and Solutions
Table 113. ORNL Nuclear Medicine Isotopes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 114. NHTC Corporate Information, Location and Competitors
Table 115. NHTC Nuclear Medicine Isotopes Major Business
Table 116. NHTC Nuclear Medicine Isotopes Total Revenue (USD Million) (2017-2018)
Table 117. NHTC SWOT Analysis
Table 118. NHTC Nuclear Medicine Isotopes Product and Solutions
Table 119. NHTC Nuclear Medicine Isotopes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 120. Urenco Corporate Information, Location and Competitors
Table 121. Urenco Nuclear Medicine Isotopes Major Business
Table 122. Urenco Nuclear Medicine Isotopes Total Revenue (USD Million) (2017-2018)
Table 123. Urenco SWOT Analysis
Table 124. Urenco Nuclear Medicine Isotopes Product and Solutions
Table 125. Urenco Nuclear Medicine Isotopes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 126. Global Nuclear Medicine Isotopes Revenue (Million USD) by Players (2015-2020)
Table 127. Global Nuclear Medicine Isotopes Revenue Share by Players (2015-2020)
Table 128. Global Nuclear Medicine Isotopes Revenue (Million USD) by Regions (2015-2020)
Table 129. Global Nuclear Medicine Isotopes Revenue Market Share by Regions (2015-2020)
Table 130. North America Nuclear Medicine Isotopes Revenue by Countries (2015-2020)
Table 131. North America Nuclear Medicine Isotopes Revenue Market Share by Countries (2015-2020)
Table 132. Europe Nuclear Medicine Isotopes Revenue (Million USD) by Countries (2015-2020)
Table 133. Asia-Pacific Nuclear Medicine Isotopes Revenue (Million USD) by Countries (2015-2020)
Table 134. South America Nuclear Medicine Isotopes Revenue by Countries (2015-2020)
Table 135. South America Nuclear Medicine Isotopes Revenue Market Share by Countries (2015-2020)
Table 136. Middle East and Africa Nuclear Medicine Isotopes Revenue (Million USD) by Countries (2015-2020)
Table 137. Middle East and Africa Nuclear Medicine Isotopes Revenue Market Share by Countries (2015-2020)
Table 138. Global Nuclear Medicine Isotopes Revenue (Million USD) by Type (2015-2020)
Table 139. Global Nuclear Medicine Isotopes Revenue Share by Type (2015-2020)
Table 140. Global Nuclear Medicine Isotopes Revenue Forecast by Type (2021-2025)
Table 141. Global Nuclear Medicine Isotopes Revenue by Application (2015-2020)
Table 142. Global Nuclear Medicine Isotopes Revenue Share by Application (2015-2020)
Table 143. Global Nuclear Medicine Isotopes Revenue Forecast by Application (2021-2025)
Table 144. Global Nuclear Medicine Isotopes Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Nuclear Medicine Isotopes Picture
Figure 2. Global Nuclear Medicine Isotopes Revenue Market Share by Type in 2019
Figure 3. Stable Isotopes Picture
Figure 4. Radioisotopes Picture
Figure 5. Nuclear Medicine Isotopes Revenue Market Share by Application in 2019
Figure 6. Nuclear Therapy Picture
Figure 7. Equipment Radioactive Source Picture
Figure 8. Diagnosis Picture
Figure 9. Global Nuclear Medicine Isotopes Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Nuclear Medicine Isotopes Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Nuclear Medicine Isotopes Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Nuclear Medicine Isotopes Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Nuclear Medicine Isotopes Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Nuclear Medicine Isotopes Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Nuclear Medicine Isotopes Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Nuclear Medicine Isotopes Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Nuclear Medicine Isotopes Revenue Market Share in 2019
Figure 18. Global Top 10 Players Nuclear Medicine Isotopes Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Nuclear Medicine Isotopes Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Nuclear Medicine Isotopes Revenue Market Share by Regions (2015-2020)
Figure 22. Global Nuclear Medicine Isotopes Revenue Market Share by Regions in 2018
Figure 23. North America Nuclear Medicine Isotopes Revenue and Growth Rate (2015-2020)
Figure 24. Europe Nuclear Medicine Isotopes Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Nuclear Medicine Isotopes Revenue and Growth Rate (2015-2020)
Figure 26. South America Nuclear Medicine Isotopes Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Nuclear Medicine Isotopes Revenue and Growth Rate (2015-2020)
Figure 28. North America Nuclear Medicine Isotopes Revenue Market Share by Countries (2015-2020)
Figure 29. North America Nuclear Medicine Isotopes Revenue Market Share by Countries in 2019
Figure 30. USA Nuclear Medicine Isotopes Revenue and Growth Rate (2015-2020)
Figure 31. Canada Nuclear Medicine Isotopes Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Nuclear Medicine Isotopes Revenue and Growth Rate (2015-2020)
Figure 33. Europe Nuclear Medicine Isotopes Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Nuclear Medicine Isotopes Revenue Market Share by Countries in 2019
Figure 35. Germany Nuclear Medicine Isotopes Revenue and Growth Rate (2015-2020)
Figure 36. UK Nuclear Medicine Isotopes Revenue and Growth Rate (2015-2020)
Figure 37. France Nuclear Medicine Isotopes Revenue and Growth Rate (2015-2020)
Figure 38. Russia Nuclear Medicine Isotopes Revenue and Growth Rate (2015-2020)
Figure 39. Italy Nuclear Medicine Isotopes Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Nuclear Medicine Isotopes Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Nuclear Medicine Isotopes Revenue Market Share by Countries in 2019
Figure 42. China Nuclear Medicine Isotopes Revenue and Growth Rate (2015-2020)
Figure 43. Japan Nuclear Medicine Isotopes Revenue and Growth Rate (2015-2020)
Figure 44. Korea Nuclear Medicine Isotopes Revenue and Growth Rate (2015-2020)
Figure 45. India Nuclear Medicine Isotopes Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Nuclear Medicine Isotopes Revenue and Growth Rate (2015-2020)
Figure 47. South America Nuclear Medicine Isotopes Revenue Market Share by Countries (2015-2020)
Figure 48. South America Nuclear Medicine Isotopes Revenue Market Share by Countries in 2019
Figure 49. Brazil Nuclear Medicine Isotopes Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Nuclear Medicine Isotopes Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Nuclear Medicine Isotopes Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Nuclear Medicine Isotopes Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Nuclear Medicine Isotopes Revenue and Growth Rate (2015-2020)
Figure 54. UAE Nuclear Medicine Isotopes Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Nuclear Medicine Isotopes Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Nuclear Medicine Isotopes Revenue and Growth Rate (2015-2020)
Figure 57. Global Nuclear Medicine Isotopes Revenue Share by Type (2015-2020)
Figure 58. Global Nuclear Medicine Isotopes Revenue Share by Type in 2019
Figure 59. Global Nuclear Medicine Isotopes Market Share Forecast by Type (2021-2025)
Figure 60. Global Stable Isotopes Revenue Growth Rate (2015-2020)
Figure 61. Global Radioisotopes Revenue Growth Rate (2015-2020)
Figure 62. Global Nuclear Medicine Isotopes Revenue Share by Application (2015-2020)
Figure 63. Global Nuclear Medicine Isotopes Revenue Share by Application in 2019
Figure 64. Global Nuclear Medicine Isotopes Market Share Forecast by Application (2021-2025)
Figure 65. Global Nuclear Therapy Revenue Growth Rate (2015-2020)
Figure 66. Global Equipment Radioactive Source Revenue Growth Rate (2015-2020)
Figure 67. Global Diagnosis Revenue Growth Rate (2015-2020)
Figure 68. Global Nuclear Medicine Isotopes Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Nuclear Medicine Isotopes Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Nuclear Medicine Isotopes Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Nuclear Medicine Isotopes Revenue Market Forecast (2021-2025)
Figure 72. Europe Nuclear Medicine Isotopes Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Nuclear Medicine Isotopes Revenue Market Forecast (2021-2025)
Figure 74. South America Nuclear Medicine Isotopes Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Nuclear Medicine Isotopes Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel

---